, that grow much slower than ure2Δ cells. Our findings give a more realistic picture of the impact of the prion change than does focus on "mild" prion variants.
A lthough mammalian prions cause a devastating and uniformly fatal spongiform encephalopathy (reviewed in ref. 1) , yeast and fungal prions, as described so far, are compatible with indefinite growth, often at normal or near-normal rates. This apparent contrast has led to proposals that the yeast and fungal prions may benefit their hosts, even though prion formation may decrease the activity of the protein as a result of the aggregate/ amyloid formation that is the prion change. The [Het-s] prion of Podospora anserina is necessary for proper heterokaryon incompatibility of het-s with het-S strains (2), so it was proposed that this is a prion benefiting the host (3). However, [Het-s] is also part of a meiotic drive system, promoting inheritance of het-s by cheating on meiosis (4) , so the beneficial prion suggestion may be wrong. [PSI + ] is an amyloid prion of the Saccharomyces cerevisiae Sup35p (5-7), and was suggested to protect against stress (8) or to promote evolution by protecting against stress (9) . All these tests of stress resistance were done using the usual [PSI + ] variants, which were selected to be compatible with vigorous cell growth (10) .
Sup35p is an essential subunit, with Sup45p, of the translation termination factor. Like the mammalian prion "strains" (11, 12) , [PSI + ] has "variants," several different stably propagated biologically and structurally different forms of the same prion protein (13, 14) . In the usual [PSI + ] variants, much of the Sup35p is tied up in amyloid filaments and is unavailable for translation termination, but enough is free to keep the cells alive. (16, 17) .
Here, we show that more than half of [PSI + ] variants are lethal or highly pathogenic, unlike the variants usually studied. Similarly, we describe abundant [URE3] variants that slow cell growth dramatically in a background in which deletion of the URE2 gene has no effect on growth. These results show that acquisition of a yeast prion may be disastrous for yeast.
Results
Sup35p has two domains, the N-terminal (NM) domain, which is necessary and sufficient for prion formation (and has physiological function as well, as discussed below) but is dispensable for growth, and the C-terminal C domain, which is essential for translation termination, and can perform this function without the NM domain. (18) and forms the core of the in-register parallel β-sheet amyloid structure that constitutes the prion form (19, 20) . To detect killer [PSI + ], the plasmid-borne SUP35C must be expressed only enough to keep cells alive but not enough for efficient termination, which would make them Ade − (Fig. S1 ). With a tetracycline-repressible promoter (Ptet rep ) (21), 10 μg/mL doxycycline sufficiently repressed the plasmid-encoded Sup35C expression that cells lacking a chromosomal SUP35 were Ade + (white) but could grow slowly (Fig. S2 ). Doxycycline at these levels does not detectably slow growth of normal cells. The tet rep -SUP35C gene was on a URA3 CEN (centromere-containing) vector whose loss could be selected by growth on plates with 5-fluorouracil (FOA; kills URA3 cells but not ura3 mutants) (22 (Fig. 4 ). An apparent correlation between [PSI + ] toxicity and the number of Sup35NM-GFP aggregates was noted (Fig. 4) (Fig. 5) . Surprisingly, most spontaneous [URE3] variants were strikingly smaller compared with the parent strain, with colonies that lost [URE3], or with the parent strain with its URE2 gene deleted (Fig. 5) . This shows that the markedly slow growth of these [URE3] variants is not a result of functional inactivation of Ure2p but, rather, was attributable to some toxic action of the prion form. These slow-growing prion variants were all unstable, producing subclones that had lost the prion as well as less toxic variants (Fig. 5 G and H) , perhaps as a result of selection for loss of toxicity. termination factor subunit, Sup45p, is drawn into the aggregates because it interacts with the nonamyloid part of Sup35p, the Cterminal domain. If Sup35NM is overexpressed, the normal (lower) amount of full-length Sup35p is entirely drawn into the amyloid filaments and the cells suffer or die (23) . Our screen was specifically designed to avoid these artificial situations to determine if there were lethal variants of [PSI + ] at normal Sup35p expression levels. Full-length Sup35p was expressed from the chromosome with the normal SUP35 promoter and context. Sup35NM was overproduced from a GAL1 promoter to induce the appearance of [PSI + ] at high frequency, but cells grew on dextrose, repressing the GAL1 promoter, for over 30 generations before they were tested for requiring the Sup35C expressed from the tet promoter. Thus, little or no Sup35NM was expressed, and full-length Sup35p was just normally expressed at the point that lethality was observed.
Discussion
Our (27) .
Our finding that more than half of [PSI + ] variants are sick or lethal highlights the danger to the cell of acquisition of a prion. Although [PSI + ] has been reported to be advantageous under certain growth conditions (8, 9) , reproducing these results has been problematic (28) . Moreover, the absence of [PSI + ] in wild strains (29) (30) (31) shows that it is not advantageous overall. Because the Sup35 prion domain in yeast and the corresponding N-terminal part of human Sup35p are important for normal mRNA degradation (32, 33) and another function (34), it is likely conserved for these purposes and prion formation in yeast may be viewed as a rare molecular degenerative disease. Moreover, yeast cells apparently view [PSI + ] and [URE3] as stress conditions, because they induce heat-shock proteins when infected (35, 36) .
Why is [PSI + ] usually nontoxic in laboratory strains? First, the most toxic variants would not be recovered without a special selection scheme. Second, the toxicity of these killer variants (and their possible inherent instability) results in frequent selection of more benign variants and cells that have lost the prion.
We find that [URE3] can dramatically slow cell growth in a strain whose growth is not slowed by deletion of the URE2 gene.
[URE3] has also been suggested to be an advantage to yeast (37) .
[URE3] is also not found in wild strains (31) , however, and the Ure2p prion domain is important for Ure2p function in stabilizing the protein against degradation in vivo (38). Taken together with our work, these results show that [URE3] is also a rare molecular degenerative disease.
There may be prions that are beneficial to yeast or other organisms, as we first suggested for [Het-s] (3). There may indeed be variants of [PSI + ] or [URE3] that aid yeast in some way. Such variants should be found in the wild under the condition in which they are a benefit (39) . Our findings also raise the question of whether there are benign variants of the mammalian prion disease. were prepared as described (40) . Prion curing was carried out by streaking to single colonies on rich plates containing 3 mM guanidine HCl.
Construction of Plasmids. Sup35C was amplified using oligos forward (5′ GG-GGGATCCAACAATGTTTGGTGGTAAAGATCACG 3′) and reverse (5′ GGGGT-TTAAACTTTACTCGGCAATTTTAACAATTTTAC 3′), cut with BamHI and PmeI, and inserted into pCM189 (21) cut with the same enzymes. This CEN URA3 plasmid (pRPM02) has the structure: tet rep promoter-BamHI-ATG-SUP35C-ter-PmeI. The CEN TRP2 plasmid pH952 contains SUP35NM under the control of a GAL promoter (gift from Herman Edskes, National Institutes of Health, Bethesda, MD). For detection of prion aggregates in vivo, centromeric plasmids pVTG12 expressing Ure2N-GFP fusion under control of the native URE2 promoter (25) and pH126 Sup35NM-GFP (31) were used. 
